Case reportPublished 16 Oct 2017

Successful Treatment of Metastatic Rectal Adenocarcinoma: A Case Report

Authors: Aniko Szentesi, Eszter Gorka, Zsuzsanna Papai

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

First-line treatment of panitumumab (Pmab) plus FOLFOX or Pmab plus FOLFIRI demonstrated improved outcomes in patients with wild-type-KRAS metastatic colorectal cancer (CRC) and liver-limited disease. We report a case of a 41 year-old man with a KRAS wild type CRC with multiple liver metastases who received first-line Pmab plus FOLFOX4 in 2014. After 5 cycles, remarkable tumor shrinkage was observed in the liver as only one reduced sized metastasis could be detected. Liver metastasectomy and after a definitive radiotherapy for the primary tumor, rectosigmoideal resection were performed. Half, then one year later two more liver metastasectomies were needed because of recurrency of the liver lesions. The patient has been tumor-free for 1.5 years due to the first-line Pmab plus FOLFOX4 treatment followed by well decided surgical resections. We consider this case as a successful treatment with a 40 months follow-up, exceeding the literature median OS data of 23.9 months.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Oncopathology and Clinical Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncopathology and Clinical Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Aniko Szentesi”
  • BylineArticles whose byline prints “Eszter Gorka”
  • BylineArticles whose byline prints “Zsuzsanna Papai”